Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease

We updated the incidence of primary hyperparathyroidism in Rochester, Minnesota. The lower rates previously noted persisted, whereas parathyroidectomies at our institution remained high. These data suggest an etiologic factor may be responsible for the peak incidence in the 1970s.

[1]  L. Melton,et al.  Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999. , 2005, Mayo Clinic proceedings.

[2]  S. Khosla,et al.  Clinical performance of parathyroid hormone immunometric assays. , 1992, Mayo Clinic proceedings.

[3]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[4]  S. Hundahl.  Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests , 1998, CA: a cancer journal for clinicians.

[5]  R. Marcus,et al.  Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. , 1984, Annals of internal medicine.

[6]  W. Black,et al.  Primary Hyperparathyroidism: Changing Clinical, Surgical and Pathologic Aspects , 1970, Annals of surgery.

[7]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[8]  Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29-31, 1990. , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  L. Melton,et al.  The epidemiology of primary hyperparathyroidism in North America. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  S. Hodgson,et al.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. , 1980, The New England journal of medicine.

[11]  J. Rastad,et al.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  R. Centor,et al.  Why physicians don't pursue abnormal laboratory tests: an investigation of hypercalcemia and the follow-up of abnormal test results. , 1984, Human pathology.

[13]  D. Meier,et al.  Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  J. Bilezikian.  Sex Steroids, Mice, and Men: When Androgens and Estrogens Get Very Close to Each Other , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Karla Kerlikowske,et al.  Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results , 2004, Annals of Internal Medicine.

[16]  H. DeLuca,et al.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. , 1979, The Journal of clinical investigation.

[17]  B. Hamberger,et al.  Primary hyperparathyroidism. Changing trends over fifty years. , 1984, Acta chirurgica Scandinavica.

[18]  D. Dempster,et al.  The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. , 1999, The American journal of medicine.

[19]  C. Marcocci,et al.  Epidemiology of primary hyperparathyroidism in Europe. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  L. Elveback,et al.  Diabetes Mellitus: Incidence, Prevalence, Survivorship, and Causes of Death in Rochester, Minnesota, 1945–1970 , 1976, Diabetes.

[21]  S. Silverberg.  Non-classical target organs in primary hyperparathyroidism. , 2002, Journal of Bone and Mineral Research.

[22]  J. Lubin,et al.  Dose-response relationships for radiation-induced hyperparathyroidism. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  A. Odén,et al.  Hyperparathyroidism subsequent to neck irradiation risk factors , 1985, Cancer.

[24]  A. Arnold,et al.  Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. , 1995, The Journal of clinical investigation.

[25]  L. Kurland,et al.  The patient record in epidemiology. , 1981, Scientific American.

[26]  S. Akiba,et al.  Hyperparathyroidism among atomic bomb survivors in Hiroshima. , 1992, Radiation research.

[27]  Q. Duh,et al.  The NIH Criteria for Parathyroidectomy in Asymptomatic Primary Hyperparathyroidism: Are They Too Limited? , 2004, Annals of surgery.

[28]  G. Åkerström,et al.  Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. , 1987, Journal of chronic diseases.

[29]  W. O'Fallon,et al.  The Rise and Fall of Primary Hyperparathyroidism: A Population-Based Study in Rochester, Minnesota, 1965-1992 , 1997, Annals of Internal Medicine.

[30]  T. Nicklas.  Calcium Intake Trends and Health Consequences from Childhood through Adulthood , 2003, Journal of the American College of Nutrition.

[31]  G. Stenström,et al.  Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. , 2009, Acta medica Scandinavica.

[32]  M. Horowitz,et al.  Renal leak of calcium in post‐menopausal osteoporosis , 1994, Clinical endocrinology.

[33]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[34]  R. Stafford,et al.  National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. , 2004, Archives of internal medicine.

[35]  L. Melton,et al.  Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn. , 1989, Archives of internal medicine.

[36]  C. Loria,et al.  Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. , 1994, Advance data.

[37]  J. Mehnert,et al.  A plethora of primary hyperparathyroidism. , 1971, Archives of surgery.

[38]  H. M. Lloyd,et al.  The effect of multiphasic biochemical screening on the diagnosis of primary hyperparathyroidism. , 1975, Australian and New Zealand journal of medicine.

[39]  Md. Hasan Raza Ansari,et al.  Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. , 2000, The Journal of clinical endocrinology and metabolism.

[40]  J. Rastad,et al.  1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells , 1988, Calcified Tissue International.

[41]  M. Holick,et al.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. , 1988, The Journal of clinical endocrinology and metabolism.

[42]  G. Mundy,et al.  PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION , 1980, The Lancet.